PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.31%
Revenue growth above 1.5x MDB's 5.79%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.79%
Gross profit growth above 1.5x MDB's 5.36%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
0.79%
Positive EBIT growth while MDB is negative. John Neff might see a substantial edge in operational management.
0.79%
Positive operating income growth while MDB is negative. John Neff might view this as a competitive edge in operations.
-149.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-147.93%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-147.93%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.08%
Share count expansion well above MDB's 1.10%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.08%
Diluted share count expanding well above MDB's 1.10%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-452.24%
Negative OCF growth while MDB is at 42.18%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-615.27%
Negative FCF growth while MDB is at 42.77%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
55.91%
10Y revenue/share CAGR under 50% of MDB's 752.18%. Michael Burry would suspect a lasting competitive disadvantage.
55.91%
5Y revenue/share CAGR under 50% of MDB's 298.60%. Michael Burry would suspect a significant competitive gap or product weakness.
55.91%
3Y revenue/share CAGR under 50% of MDB's 123.96%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
46.47%
10Y OCF/share CAGR under 50% of MDB's 401.66%. Michael Burry would worry about a persistent underperformance in cash creation.
46.47%
Below 50% of MDB's 528.70%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
46.47%
3Y OCF/share CAGR under 50% of MDB's 344.99%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-34.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-34.27%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-34.27%
Negative 3Y CAGR while MDB is 38.82%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
173.60%
10Y equity/share CAGR at 50-75% of MDB's 307.81%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
173.60%
5Y equity/share CAGR at 75-90% of MDB's 200.60%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
173.60%
Below 50% of MDB's 17860.34%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.48%
AR growth well above MDB's 19.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
-17.95%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.87%
Asset growth well under 50% of MDB's 6.52%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-4.79%
We have a declining book value while MDB shows 9.28%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.22%
We’re deleveraging while MDB stands at 3.59%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
20.73%
R&D growth drastically higher vs. MDB's 13.58%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
13.94%
SG&A growth well above MDB's 10.63%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.